Efficacy and safety of Oxcarbazepine versus Phenytoin in controlling post stroke seizures in the elderly


Warning: No corresponding author defined!

How to Cite: Efficacy and safety of Oxcarbazepine versus Phenytoin in controlling post stroke seizures in the elderly, Jentashapir J Cell Mol Biol. Online ahead of Print ; 3(3):445-450.


Jentashapir Journal of Health Research: 3 (3); 445-450
Published Online: June 30, 2012
Article Type: Research Article
Received: April 3, 2012
Accepted: June 5, 2012


Background: The prevalence of epilepsy in the elderly is more than other age groups and treatment of epilepsy in this group is challenging for neurologists. The purpose of this study is to compare the efficacy and safety of phenytoin versus oxcarbazepine in the elderly patients with newly diagnosed secondary generalized seizure.

Material and methods: We enrolled 142 elderly patients with epilepsy after considering the measures of exclusion and inclusion criteria. The patients were divided in two groups (A&B) randomly. For the group A phenytoin capsule ( >70 y/o 100mg BID & <70 y/o 100mg TDS) and the group B oxcarbazepine 300mg BID tablet were administered in a double blind manner. Through this study all patient were followed up for side effects and their response to treatment (not having seizure) for 6 months .

Results: In group A 91.5% of the patients ( n=54) were seizure free in the period of 6 months and in the group B 86.6% of the patients ( n=58) were seizure free ( p=0.377). The frequency of adverse effects was 18.2% in the group A (n=12) and in the group B 6.5% ( n=4) of the patients had adverse effects ( p=0.045).

Full Text

Full text is available in PDF

© 2012, Jentashapir Journal of Cellular and Molecular Biology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.